Table 3.

Adjusted all-cause mortality HRs associated with AKI for various subgroups

ParameterWith AKI (n = 82,711)No AKI (n = 782,222)Adjusted Mortality HRa95% CI
Baseline eGFR (ml/min per 1.73 m2)
    ≥9044,641 (54.0%)365,520 (46.7%)1.451.42 to 1.48
    ≥60, <9026,042 (31.5%)322,818 (41.3%)1.351.32 to 1.39
    ≥45, <607983 (9.7%)68,361 (8.7%)1.311.25 to 1.36
    ≥30, <454045 (4.9%)25,523 (3.3%)1.231.16 to 1.30
Age
    <507992 (9.7%)165,965 (21.2%)1.841.72 to 1.96
    50 to 5919,897 (24.1%)225,033 (28.8%)1.621.56 to 1.68
    60 to 6918,910 (22.9%)153,699 (19.7%)1.421.37 to 1.46
    70 to 7924,176 (29.2%)162,688 (20.8%)1.311.28 to 1.34
    ≥8011,736 (14.2%)74,837 (9.6%)1.241.20 to 1.28
Gender
    female2683 (3.2%)39,405 (5.0%)1.491.34 to 1.65
    male80,028 (96.8%)742,817 (95.0%)1.411.39 to 1.43
Diabetes status
    no diabetes54,897 (66.4%)603,326 (77.1%)1.441.42 to 1.47
    diabetes27,814 (33.6%)178,896 (22.9%)1.331.29 to 1.36
  • aAdjusted for demographics, comorbidities and medication use, hospitalization details, and postdischarge eGFR categories.